Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim in Cortico-Dependent Crohn's Disease
NCT00206596Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2003
- Primary completion
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of sargramostim in Crohn's disease, sponsored by Sanofi. Started Jul 2003; status: completed.
02
Drugs
sargramostim
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00206596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206596.